Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.

Raimondo Di LielloLaura ArenareFrancesco RaspagliesiGiovanni ScambiaCarmela PisanoNicoletta ColomboSimona FrezziniGermana TognonGrazia ArtioliAngiolo GadducciRossella LauriaAnnamaria FerreroSaverio CinieriAndrea De CensiEnrico BredaPaolo ScolloUgo De GiorgiAndrea Alberto LissoniDionyssios KatsarosDomenica LorussoVanda SalutariSabrina Chiara CecereMariateresa LapresaMargherita NardinGiorgio BoganiMariagrazia DistefanoStefano GreggiPiera GargiuloClorinda SchettinoCiro GalloGennaro DanieleDaniela CalifanoFrancesco PerroneSandro PignataMaria Carmela Piccirillo

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)

NCT01706120.

Keyphrases

atrial fibrillation
phase iii
study protocol
phase ii
clinical trial
metastatic colorectal cancer
randomized controlled trial